Alterations in erythrocyte aggregability in diabetics: The influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane

Clinical Hemorheology and Microcirculation

Volumn 18, Issue 4, 1998, Pages 253-258

  Martinez M ^a   Vaya A ^a   Server, R ^a   Gilsanz, A ^a   Aznar, J ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Diabetes; Erythrocyte aggregation; Fibrinogen; RBC membrane's phospholipids

Indexed keywords

FIBRINOGEN; MEMBRANE PHOSPHOLIPID;

ADULT; ARTICLE; BLOOD RHEOLOGY; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE MEMBRANE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ERYTHROCYTE AGGREGATION; ERYTHROCYTE MEMBRANE; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPIDS;

EID: 0031819739     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. J.J. Abrams, H. Ginsberg and S.M. Grundy, Metabolism of cholesterol and plasma triglycerides in nonketonic diabetes mellitus, Diabetes 31 (1982), 903-910.
2. B. Bauduceau, C. Renaudeau, H. Mayaudon, C. Helie, M. Ducorps, E. Sonnet and J.P. Yvert, Modification des paramètres hémorheologiques au cours des complications microangiopathiques du diabète, Diabète Metab. 21 (1995), 188-193.
3. R.E. Brown, in: Subcellular Biochemistry, Vol. 16, Intracellular Transfer of Lipid Molecules, H.J. Hilderson, ed., Plenum Press, New York, 1991, pp. 333-363.
4. K.R. Bruckdorfer and J.M. Graham, The exchange of cholesterol and phospholipids between cell membranes and lipoproteins, in: Biological Membranes, Vol. 3, D. Chapman and D.F. Wallack, eds, Academic Press, London, 1976, pp. 103-152.
5. C. Bucherer, C. Lacombe, J.C. Lelièvre, C. Sachon, F. Bosquet and A. Grimaldi, Relevance of measuring red blood cell disaggregability in insulin-dependent diabetic patients, J. Diabetes Compl. 6 (1992), 175-179.
6. A. Ceriello, C. Taboga, R. Giacomello, E. Falleti, G. De Stasio, E. Motz, S. Lizzio, F. Gonano and E. Bartoli, Fibrinogen plasma levels as a marker of thrombin activation in diabetes, Diabetes 43 (1994), 430-432.
7. S. Chien and L.A. Sung, Physicochemical basis and clinical implications of the red cells aggregation, Clin. Hemorheol. 7 (1987), 71-91.
8. T.W. Chung, A.G. Liu and J.H. Yu, Increased red cell rigidity might affect retinal capillary blood flow velocity and oxygen transport efficiency in type II diabetes, Diabetes Res. 23 (1993), 75-82.
9. V. Cogan and D. Schachter, Asymmetry of lipids dynamics in human erythrocyte membranes studied with impermeant fluozophores, Biochemistry 20 (1981), 6396-6402.
10. J.T. Dodge, C. Mitchell and D.J. Hanahan, The preparation and chemical characteristics of hemoglobin free ghosts of human erythrocytes, Arch. Biochem. Biophys. 100 (1963), 119-130.
11. F.L. Dunn, P. Caroll, F. Vlachokosta and B. Beltz, Effects of treatment with the artificial beta cell on triglyceride metabolism in type I diabetes mellitus, Diabetes 1 (1985), 86A.
12. C. Fossat, P. Bonitchi, P. Vague, M. Mirshahi, J. Soria, C. Soria and I. Juhan-Vague, The effect of plasma proteins and glycosylated fibrinogen on red blood cell aggregation in diabetes, Clin. Hemorheol. 11 (1991), 649-654.
13. O.P. Ganda and C.F. Arkin, Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes, Diabetes Care 15 (1992), 1245-1250.
14. I. Juhan-Vague, F. Driss, C. Rou, P.H. Darcet, M.F. Aillaud and P.H. Vague, Abnormalities of erythrocyte membrane lipids in insulin-dependent diabetics are improved by short-term strict control of diabetes, Clin. Hemorheol. 4 (1984), 455-459.
15. T. Khodabandehlou and C. Le Dévéhat, Activation du plasminogène et agregation erythrocytaire chez les patients diabètiques, J. Mal. Vasc. 19 (1994), 190-194.
16. T. Khodabandehlou, C. Le Dévéhat, M. Razavian, M. Boynard and M. Ba, Capacite fonctionnelle du fibrinogène et agregation erythrocytaire chez le diabètique, J. Mal. Vasc. 19 (1994), 278-282.
17. T. Khodabandehlou, C. Le Dévéhat and M. Razavian, Impaired function of fibrinogen: consequences on red cell aggregation in diabetes mellitus, Clin. Hemorheol. 16 (1996), 303-312.
18. L.G. Krebs, D. Heusser and H. Wimmer, in: Thin Layer Chromatography. A Laboratory Handbook, E. Sthal, ed., 2nd edn, Springer, New York, 1969, p. 887.
19. C. Le Dévéhat, T. Khodabandehlou, M. Vimeux and F. Aouane, Diabetes mellitus: its effects on blood Theological properties and microcirculatory consequences, Clin. Hemorheol. 16 (1996), 677-683.
20. A.J. Lee, G.D. Lowe, M. Woodward and H. Tunstall Pedoe, Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease and family history: The Scottish Heart Health Study, Br. Heart J. 69 (1993), 338-342.
21. P. Luly, Membrane lipid changes in the abnormal red cell, in: The Red Cell Membrane, B.U. Raes Tunnicliff, ed., Human Press, Clifton, NJ, 1989, pp. 399-421.
22. S.M. MacRury, S.E. Lennie, P. McColl, R. Balendra, A.C. MacCuish and G.D. Lowe, Increased red aggregation in diabetes mellitus: association with cardiovascular risk factors, Diabet. Med. 10 (1993), 21-26.
23. N. Maeda, M. Seike, S. Kume, T. Takaku and T. Shiga, Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule, Biochim. Biophys. Acta 904 (1987), 81-91.
24. E. Morishita, H. Asakura, H. Jokaji, M. Saito, C. Uotani, I. Kumabashiri, M. Yamazaki, K. Aoshima, T. Hashimoto and T. Matsuda, Hypercoagulability and high lipoprotein (a) levels in patients with type II diabetes mellitus, Atherosclerosis 120 (1996), 7-14.
25. A. Othmane, M. Bitbol, P. Snabre and P. Mills, Influence of altered phospholipid composition of the membrane outer layer on red blood cell aggregation: relation to shape changes and glycocalyx structure, Eur. Biophys. J. 18 (1990), 93-99.
26. S.U. Persson, G. Wohlfart, H. Laarsson and A. Gustafson, Correlation between fatty acid composition of the erythrocyte membrane and blood rheology data, Scand. J. Clin. Lab. Invest. 56 (1996), 183-190.
27. D. Prisco, R. Paniccia, M. Coppo, D. Vani, P.G. Rogasi, M. Tramontana, R. Abbate and G.F. Gensini, Red blood cell lipid alterations in type II diabetes mellitus, Thromb. Res. 54 (1989), 751-758.
28. B. Roelofsen and R.F.A. Zwaal, The use of phospholipase in the determination of asymmetric phospholipid distribution in membranes, Meth. Membr. Biol. 7 (1976), 147-152.
29. M.E. Rogers, D.T. Williams, R. Nithhyananthan, M.W. Rampling, K.E. Heslop and D.G. Johnston, Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes, Clin. Sci. Colch. 82 (1992), 309-313.
30. H.G. Rose and M. Oklander, Improved procedure for the extraction of the lipids of the human erythrocytes, J. Lipid Res. 65 (1965), 428-431.
31. A. Sabo, V. Jakovljevic, M. Stanulovic, L. Lepsanovic and D. Pejin, Red blood cell deformability in diabetes mellitus: effect of phytomenadione, Int. J. Clin. Pharmacol. Ther. Toxicol. 31 (1993), 1-5.
32. S. Sayinalp, T. Sozen, A. Usman and S. Dundar, Investigation of the effect of poorly controlled diabetes mellitus on erythrocyte life, J. Diabetes Compl. 9 (1995), 190-193.
33. H. Schmid-Schonbein, E. Volger, P. Teitel, H. Kiesewetter, V. Daver and L. Heilmann, New hemorheological techniques for the routine laboratory, Clin. Hemorheol. 3 (1983), 93-95.
34. V.P. Skipski, in: Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism, G.J. Nelson, ed., Wiley-Interscience, New York, 1972, pp. 471-583.
35. C. Snowden, R. Houlston, M.F. Laker, P. Kesteven, K.G. Alberti and S.E. Humphries, Plasma fibrinogen levels and fibrinogen genotype in non-insulin-dependent diabetics, Dis. Markers 10 (1992), 159-167.
36. G. Steiner, The dyslipoproteinemias of diabetes, Atherosclerosis 110(Suppl.) (1994), 27-33.
37. M.Y. Tsai and J.G. Marshall, Phosphatidylglycerol in 261 samples of amniotic from normal and diabetic pregnancies as measured by one-dimensional thin-layer chromatography, Clin. Chem. 25 (1979), 682-685.
38. J. Valles, M.T. Santos, J. Aznar, M. Velert, G. Barbera and R. Carmena, Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients, Diabetes (in press).
39. R.K. Wali, S. Jaffe, D. Kumar and V.K. Kalra, Alterations in organization of phospholipids in erythrocytes as factor in adherence to endothelial cells in diabetes mellitus, Diabetes 37 (1988), 104-111.
40. O. Ziegler, B. Guerci, S. Muller, H. Candiloros, L. Mejean, M. Donner, J.F. Stoltz and P. Drouin, Increased erythrocyte aggregation in insulin-dependent diabetes mellitus and its relationship to plasma factors: a multivariate analysis, Metabolism 43 (1994), 1182-1186.